Subspecialization and Pancreaticoduodenectomy: Learning Experience from 71 Consecutive Cases  by Yuen, John S. et al.
ASIAN JOURNAL OF SURGERY  VOL 27 • NO 2 • APRIL 2004 73
070/2001
Original Article
© 2004 Elsevier. All rights reserved.
Introduction
Pancreaticoduodenectomy (PD) was first introduced by
Whipple and his associates in 1935.1 The high hospital mortal-
ity rate of approximately 25% in the 1970s2 hampered the
widespread use of this procedure. In recent years, PD has been
shown to be a safe procedure in selected patients, even in older
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patients.3 The operative mortality following PD is now below
5% in many large specialized tertiary centres.4–11 With the
improvement in mortality, there has been a trend towards
extending the indications for this procedure to benign condi-
tions such as chronic pancreatitis and trauma.8,9,11
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BACKGROUND: Pancreaticoduodenectomy (PD) is a major procedure with significant mortality and morbidity.
In this study, we reviewed our departmental results with PD as subspecialization for hepatopancreaticobiliary
surgery developed, and evaluated the effects on surgical technique and practice.
METHODS: Between January 1995 and October 2000, 71 consecutive patients underwent PD for various
diseases at our institution. Patients were analysed in two groups according to the 35-month time period in which
they underwent surgery: Group A, January 1995 to November 1997 (n = 28), and Group B, December 1997 to
October 2000 (n = 43).
RESULTS: The two groups were comparable for age, gender distribution, race and associated medical illnesses.
Overall 30-day mortality was 5.6% (n = 4); three patients (10.7%) died in Group A and one (2.3%) in Group B.
Compared to Group A, there was less surgery-related morbidity (25% vs 16.3%), intraoperative median blood loss
(700 mL vs 500 mL), and median intensive-care stay (2 days vs 1 day) in Group B. No significant changes were noted
in the overall complication rates (35.7% vs 39.5%), median operating time (4.7 vs 6.1 hours), median blood
transfusion requirement (1.46 vs 1.29 units), and median hospital stay (17 vs 18 days). There was a significant shift
away from pancreaticojejunostomy (PJ) reconstruction towards pancreaticogastrostomy (PG), especially in
Group B. Although preoperative histological confirmation of carcinoma was important in the earlier group, there
was less emphasis on this need for a diagnosis before resection in the later period.
CONCLUSIONS: Subspecialization in our department has improved the results of PD to an acceptable level,
with a mortality of only 2.3%. However, this procedure still causes morbidity, with surgery-related morbidity of
16.3% even with subspecialization. Whether further reductions in morbidity can be achieved with more technical
innovations remains to be seen. PG reconstruction was safer than PJ in our practice, with no anastomotic leaks.
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The Department of Surgery started subspecialization teams in
1989 but did not establish a hepatopancreaticobiliary (HPB)
unit until after 1996. In spite of this, most PD cases were
performed by the HPB unit only from the end of 1997. PD in
the department was traditionally performed by senior general
surgeons. A conservative approach was taken towards PD
because of the high mortality and morbidity traditionally
associated with the procedure. A preoperative or intraopera-
tive histological diagnosis of carcinoma was required prior
to PD, unless the radiological imaging diagnosis was convinc-
ing. With the introduction of HPB as a subspecialty in the
department, there was a gradual shift towards PD being per-
formed more by trained subspecialists rather than all general
surgeons. In addition, there was an increasing need to review
the requirements of a positive histology of carcinoma before
proceeding to a PD because of the possibility of false-negative
histology, especially in the presence of associated chronic
pancreatitis.
Given this situation, this audit reviewed the last 5 years’
experience of PD in our department and identified changing
trends with respect to whether subspecialization influenced
mortality, morbidity and the technique and practice of PD.
Patients and methods
This was a retrospective review of 71 patients who underwent
PD for various diseases at our institution from January 1995 to
October 2000. Patient demographic and preoperative investi-
gation data were collected. Intraoperative data including op-
erative time, blood loss and blood transfusion requirements
were recorded. Variations in surgical technique, e.g. type of
resection (pylorus-preserving PD or Whipple’s procedure) and
the type of pancreaticoenteric reconstruction, either pancrea-
ticogastrostomy (PG) or pancreaticojejunostomy (PJ), were
analysed.
Histopathological reports were scrutinized for informa-
tion on benign and malignant lesions. The type, grade, site and
size of tumours, extent of invasion into adjacent organs and
lymph nodes, and involvement of margins were also recorded.
Postoperative data included the duration of intensive-care
stay, surgery-related major complications (e.g. anastomotic
leak, intra-abdominal abscess, wound dehiscence and bleed-
ing from the anastomotic site), and general complications.
Data on the indications and outcome for re-operation, 30-day
mortality, and postmortem findings were also analysed.
Overall data from the 70-month study period were analysed.
In addition, in an effort to detect trends in operative morbidity
and mortality, the results in two groups of patients (group A
and B), divided arbitrarily on the basis of two 35-month
periods, were compared. The division at the cut-off of Novem-
ber 1997 coincided with the time beyond which most PD cases
were performed by the HPB unit. Thus, comparison of results
between the two groups would test our hypothesis that
subspecialization improved surgical results. Group A con-
sisted of patients who underwent surgery between January
1995 and November 1997 (n = 28), and Group B consisted of
those who underwent surgery between December 1997 and
October 2000 (n = 43). All data were analysed using the Statis-
tical Package for Social Sciences version 9.0 (SPSS Inc, Chicago,




Demographic data, presentations, indications and preoperative
investigation findings of this cohort of patients are listed in
Table 1. There were 34 males and 37 females. Ages ranged from
16 to 87 years, with a mean of 59 years. All patients who were
deemed fit for general anaesthesia were offered the operation,
and age was not used as a contraindication. In patients who
had periampullary lesions, jaundice (the most common pre-
senting feature) was present in 46 patients (64.8%). In 12
patients (16.9%), the diagnosis was made incidentally on
imaging (n = 11) and raised serum CA 19-9 level (n = 1). There
was no statistically significant difference between the two
groups in terms of age, gender distribution, race, associated
medical illnesses, and presenting symptoms.
An overwhelming majority of the resections (67 patients,
94.4%) were performed for proven periampullary malignant
lesions or for lesions for which there was a high degree of
suspicion of malignancy preoperatively. Five patients had
suspicious lesions preoperatively that turned out to be benign
on final histology. Three of the four patients who underwent
surgery for known benign disease were in Group B. One of
these patients had intractable pain due to chronic pancreatitis
secondary to pancreas divisum. One patient underwent emer-
gency PD for traumatic rupture of the pancreas and duodenum.
One patient had a preoperative histological diagnosis of vil-
lous adenoma and another had transmural infarction of the
duodenum with profuse bleeding necessitating emergency
resection.
There were data from combined computed tomography
(CT) and endoscopic retrograde cholangiopancreaticography
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Table 1. Patient profile, comorbidities, preoperative investigations and indications
Jan 1995–Oct 2000 Group A Group B p
(N = 71) (n = 28) (n = 43)
Age (yr)
Range 16–87 33–87 16–78 NS
Mean 58.8 61.8 56.8 NS
Median 63.5 65.5 61.0 NS
Gender
Male 34 (47.9%) 14 (50.0%) 20 (46.5%) NS
Female 37 (52.1%) 14 (50.0%) 23 (53.5%) NS
M:F 1:1.1 1:1 1:1.2 NS
Race
Chinese 62 (87.3%) 22 (78.6%) 40 (93.0%) NS
Malay 7 (9.9%) 14 (14.3%) 3 (7.0%) NS
Indian 2 (2.8%) 2 (7.1%) 0 NS
Medical illness
IHD 26 (36.6%) 12 (42.9%) 14 (32.6%) NS
DM 20 (28.2%) 19 (32.1%) 11 (25.6%) NS
COPD 4 (5.6%) 2 (7.1%) 2 (4.7%) NS
Stroke 2 (2.8%) 0 2 (4.7%) NS
Renal impairment 4 (5.6%) 2 (7.1%) 2 (4.7%) NS
Other malignancy 2 (2.8%) 0 2 (4.7%) NS
Presentation
Jaundice 46 (64.8%) 18 (64.3%) 28 (65.1%) NS
Weight loss 23 (32.4%) 18 (28.6%) 15 (34.9%) NS
Dyspepsia 6 (8.5%) 1 (3.6%) 15 (11.6%) NS
Pain 22 (31.0%) 13 (46.4%) 19 (20.9%) NS
Mass 1 (1.4%) 1 (3.6%) 0 NS
Incidental 12 (16.9%) 14 (14.3%) 18 (18.6%) NS
Preoperative investigations
CT 65 (91.5%) 27 (96.4%) 38 (88.4%)
ERCP 62 (87.3%) 26 (92.9%) 32 (74.4%)
CT + ERCP 53 (74.6%) 25 (89.3%) 28 (65.1%)
MRI/MRCP 6 (8.5%) 0 16 (14.0%)
CA 19-9/mean (U/Ml)            47 (66.2%)/441.1            14 (50.0%)/576.4            33 (76.7%)/384.8
Indications
Malignant tumour
   Adenocarcinoma 55 (77.5%) 20 (71.4%) 35 (81.4%)
      Pancreas 17 (30.9%) 16 (30.0%) 11 (31.4%)
      Ampullary 34 (61.8%) 13 (65.0%) 21 (60.0%)
      Distal CBD 4 (7.3%) 1 (5.0%) 3 (8.6%)
   Other malignant tumours 7 (9.9%) 14 (14.3%) 3 (7.0%)
Benign neoplasms 5 (7.0%) 13 (10.7%) 2 (4.7%)
Non-neoplastic
   Chronic pancreatitis 2 (2.8%) 1 (3.6%) 1 (2.3%)
   Others 2 (2.8%) 0 2 (4.7%)
NS = not significant; IHD = ischaemic heart disease; DM = diabetes mellitus; COPD = chronic obstructive pulmonary disease;
CT = computed tomography; ERCP = endoscopic retrograde cholangiopancreaticography; MRI = magnetic resonance imaging; MRCP =
magnetic resonance cholangiopancreaticography; CBD = common bile duct.
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(ERCP) for 53 patients (74.6%). Six patients (14.0%) in Group
B underwent magnetic resonance cholangiopancreaticogra-
phy (MRCP) instead of ERCP as this imaging modality became
available in our centre. Abnormal levels of CA 19-9 were
recorded in 47 patients (66.2%).
Table 2 shows the preoperative histological work-up of
patients. From a total of 66 patients, a preoperative histologi-
cal diagnosis of periampullary malignancy was obtained in 38
patients (57.6%) through ERCP-obtained tissue biopsies. Thir-
teen patients (19.7%) underwent laparotomy without positive
preoperative histological proof of malignancy but had intra-
operative confirmation of malignancy before proceeding to
PD. Of these patients, three had a negative ERCP and the
remaining 10 had no preoperative biopsy performed. Thus,
77.3% of patients had positive histological diagnosis of malig-
nancy either pre- or intraoperatively before proceeding to PD.
Fifteen patients (22.7%) had negative or no histological
diagnosis of malignancy before PD. In 11 of these patients, no
preoperative biopsy and no intraoperative frozen section
biopsy were performed. Ten of these 11 patients (91.0%)
had malignant disease on histological examination of the
specimens, and the other had benign disease (9 adenocar-
cinoma, 1 sarcoma and 1 intraductal mucinous papillary
carcinoma). Of the remaining four patients out of the 15,
two (50.0%) were proven to have malignant disease on final
histology. In short, 64 patients underwent PD for malignant
disease, with 51 (79.7%) of these confirmed histologically
either pre- or intraoperatively. Of the 15 patients with a high
index of suspicion of malignancy but no pre- or intraoperative
histological diagnosis, 12 (80.0%) proved to be malignant at
final histology.
Intraoperative findings
There was a reduction in mean blood loss from 700 mL in
Group A to 500 mL in Group B, although this was not statis-
tically significant. Likewise, there were no statistically signifi-
cant differences in mean operating time (Group A: 4 hours 56
minutes; Group B: 5 hours 54 minutes) and median blood
transfusion requirement (Group A: 1.46 units; Group B: 1.29
units).
Sixty-nine patients (97.2%) underwent subtotal pancrea-
tectomy, and the remaining two patients underwent total
pancreatectomy (Table 3). In one patient, the pancreatic duct
of a small remnant pancreas was ligated without pancreatico-
enteric anastomosis. Most pancreaticoenteric anastomoses
(73.2%) were PG; only 16 patients (22.5%) underwent PJ.
Classic PD with subtotal gastrectomy was performed in 61
patients (85.9%), while 10 patients (14.1%) underwent pylorus-
preserving PD. In one patient, portal vein resection with recon-
struction was required due to tumour involvement.
Table 2. Preoperative histological diagnosis of periampullary malignant tumour
Jan 1995–Oct 2000 Group A Group B
(N = 66) (n = 28) (n = 38)
Preoperative positive histology 51 (77.3%) 22 (81.5%) 29 (74.4%)
ERCP +ve histology 38 (57.6%) 17 (63.0%) 21 (53.8%)
ERCP –ve, F/S +ve 3 (4.5%) 0 3 (7.7%)
No preoperative biopsy, F/S +ve 10 (15.2%) 15 (18.5%) 15 (12.8%)
No preoperative biopsy, F/S –ve 4 (6.1%) 1 (3.7%) 3 (7.7%)
No preoperative biopsy, no F/S 11 (16.7%) 15 (18.5%) 16 (15.4%)
ERCP = endoscopic retrograde cholangiopancreaticography; F/S = frozen section; +ve = positive; –ve = negative.
Table 3. Surgical variations
Jan 1995–Oct 2000 Group A Group B
(N = 71) (n = 28) (n = 43)
Pancreaticogastrostomy 52 (73.2%) 18 (64.3%) 34 (79.1%)
Pancreaticojejunostomy 16 (22.5%) 18 (28.6%) 18 (18.6%)
Total pancreatectomy 2 (2.8%) 1 (3.6%) 1 (2.3%)
Pyloric sparing 10 (14.1%) 18 (28.6%) 2 (4.7%)
Feeding jejunostomy 10 (14.1%) 18 (28.6%) 2 (4.7%)
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Postoperative results
Table 4 presents the mortality and morbidity data for this
cohort of patients. There were four deaths (mortality rate,
5.6%): three in Group A (10.7%) and one in Group B (2.3%). The
causes of death were intra-abdominal sepsis secondary to PJ
anastomotic leak (n = 2), haemorrhage from disseminated
intravascular coagulopathy after portal vein resection (n = 1),
and bronchopneumonia (n = 1).
Postoperative complications can be divided into surgery-
related complications and general complications. Twenty-
seven patients (38.0%) developed at least one postoperative
complication. Fourteen patients (19.7%) had at least one ma-
jor surgery-related complication; of these, eight had anasto-
motic leakage, one had wound dehiscence, 10 had intra-
abdominal abscess formation, and three had postoperative
bleeding. Four (25.0%) of the 16 patients who underwent PJ
had anastomotic leakage at the PJ site. In addition, there was
one hepaticojejunostomy (HJ) leakage in the PJ group. There
was no pancreatic anastomotic leak in the 52 patients with PG
anastomosis. However, in this group of patients, one had
gastrojejunostomy (GJ) leakage and two had HJ leakage.
Eleven patients (15.5%) underwent repeat surgery. Three
patients each had revision of PJ and HJ anastomoses. One
patient (1.4%) had revision of GJ anastomosis. One patient had
re-laparotomy to stop bile leak from a small biliary pedicle in
the gallbladder fossa. One patient had open drainage of a
subcutaneous abscess. Two patients (2.8%) had repeat surgery
to stop bleeding from the PG and GJ anastomotic sites, re-
spectively. In addition, one patient had bleeding from the GJ
site, which was treated successfully with endoscopic adrena-
line injection therapy. Postoperative hospital stay ranged from
9 to 67 days, with a mean of 21 days and a median of 17 days.
Table 4. Postoperative mortality and morbidity
Jan 1995–Oct 2000 Group A Group B p
(N = 71) (n = 28) (n = 43)
30-day mortality 4 (5.6%) 13 (10.7%) 1 (2.3%) 0.172 (NS)
Morbidity
Overall 27 (38.0%) 10 (35.7%) 17 (39.5%) NS
Surgery-related 14 (19.7%) 17 (25.0%) 17 (16.3%) NS
   Anastomotic leakage* 18 (11.3%) 2 (7.1%) 16 (14.0%) NS
   Wound dehiscence 1 (1.4%) 1 (3.6%) 0
   Intra-abdominal abscess 10 (14.1%) 15 (17.9%) 15 (11.6%) NS
   Bleeding 3 (4.2%) 1 (3.6%) 2 (4.7%) NS
General complications
   AMI/arrhythmia 5 (7.0%) 2 (7.1%) 3 (7.0%) NS
   Pneumonia 10 (14.1%) 13 (10.7%) 17 (16.3%) NS
   Stroke 1 (1.4%) 0 1 (2.3%) NS
   Urinary infection 5 (7.0%) 1 (3.6%) 4 (9.3%) NS
Re-operation 11 (15.5%) 15 (17.9%) 16 (14.0%) NS
Type of anastomotic leak*
   PG 0 0 0
   PJ 4 1 3
   GJ 1 1 0
   CJ/HJ 3 0 3
Duration of ICU stay (d)
   Mean 11.8 12.1 11.6 NS
   Median 11.0 12.0 11.0 NS
Duration of hospital stay (d)
   Mean 21.0 19.6 22.0 NS
   Median 17.0 17.0 18.0 NS
AMI = acute myocardial infarction; PG = pancreaticogastrostomy; PJ = pancreaticojejunostomy; GJ = gastrojejunostomy; CJ =
choledochojejunostomy; HJ = hepaticojejunostomy; ICU = intensive care unit.
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However, there was no significant difference in median hospi-
tal stay between the two groups (17 vs 18 days).
Histopathological analysis
The final pathological diagnoses from the resected specimens
are listed in Table 5. Sixty-two patients (87.3%) had malignant
tumour of the periampullary region; periampullary adenocar-
cinoma was found in 55 patients (77.5%): the characteristics
and distributions of the tumours are shown in Table 1. Seven
patients (9.9%) had other malignant tumours. Nine patients
(12.7%) had benign conditions on final histology. Five patients
(7.0%) had benign neoplasms. Two patients had chronic
pancreatitis, one had bleeding from a transmural duodenal
infarction, and one underwent PD for traumatic rupture of
the pancreas and duodenum.
Discussion
Increasing numbers of PDs are being performed at our
institution. In this study, one-third were performed in the first
35 months compared with two-thirds in the second half of the
study period. There was no significant difference in patient
demography. Although the indication for PD was mainly
suspected or proven malignancy (94.4%), in the later time
frame, four patients underwent the procedure for known
benign conditions. The expansion of indications to include
benign diseases is a reflection of subjective improvements in
PD outcomes. This has yet to be shown with objective im-
provement in mortality and/or morbidity rates.
The overall postoperative 30-day mortality of 5.6% was
acceptable. The improvement in the mortality rate from 10.7%
in the first half of the study period to 2.3% in the later half is
consistent with the trend of improving results reported in the
literature.8,10 This improvement could be due to improve-
ments in postoperative intensive care, advances in anaesthe-
sia, and subspecialization and increased experience with the
procedure.8,11 Patient selection did not play a part in improv-
ing outcome as there was no difference in patient demographics
between the two periods. In addition, there was a decrease
in the rate of surgery-related major complications from 25%
to 16.3%, and a decrease in mean blood loss from 700 mL to
500 mL. However, the morbidity due to anastomotic leak
was higher in Group B than in Group A (14.0% vs 7.1%);
PJ accounted for the major source of anastomotic leakage
Table 5. Pathological analysis
Jan 1995–Oct 2000 Group A Group B
(N = 55) (n = 20) (n = 35)
Adenocarcinoma differentiation
Well differentiated 19 (16.4%) 1 (5.0%) 18 (22.9%)
Moderately differentiated 33 (60.0%) 14 (70.0%) 19 (54.3%)
Poorly differentiated 13 (23.6%) 15 (25.0%) 18 (22.9%)
Mean tumour diameter, cm (range) 2.7 2.71 (1–6)   2.70 (0.5–8)
Margin status
Negative 51 (92.7%) 18 (90.0%) 33 (94.3%)
Positive 4 (7.3%) 12 (10.0%) 2 (5.7%)
Stage
T1N0 5 (9.1%) 1 (5.0%) 14 (11.4%)
T1N1 3 (5.5%) 1 (5.0%) 2 (5.7%)
T2N0 27 (49.1%) 10 (50.0%) 17 (48.6%)
T2N2 20 (36.4%) 18 (40.0%) 12 (34.3%)
Benign neoplasms
Intraductal papillary mucinous tumour (non-invasive)
Adenomatous polyp of ampulla of Vater
Encapsulated endocrine tumour
Tubulovillous adenoma of ampulla of Vater
Pancreatic endocrine tumour of unknown malignancy
Other malignant neoplasms
Villous adenoma of ampulla with early malignant change
Mucin-producing intraductal invasive carcinoma
Malignant endocrine tumour
High-grade sarcoma
Mucinous carcinoma of ampulla of Vater
Lymphoma
Low-grade endocrine carcinoma
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(1 patient or 50% of all leaks in Group A, 3 patients or 50% of
all leaks in Group B) (Table 4). With the total switch to PG in
the later period, no pancreaticoenteric anastomotic leak was
reported. Nevertheless, although there was significant im-
provement in the mortality rate with subspecialization, PD
remained a morbid procedure. The morbidity rate in this
study was comparable to those of other reports.8,9
There was a clear shift from performing PJ to PG for
pancreaticoenteric reconstruction in the latter study period.
This was prompted by the observations of an increasing inci-
dence (25%) of anastomotic leak attributed to PJ anastomosis.
There was no PG anastomotic leak in this series. Our depart-
ment has also previously shown that patients with PG recon-
struction post-PD maintained good nutrition and quality of
life.12 Thus, the practice of this institution was heavily biased
towards PG, especially towards the latter half of the study
when the surgeons keen on PJ had left the department. This
shift in practice could explain the decrease in major surgery-
related complications. Our findings here are contrary to those
of other reports, which showed no difference between PJ and
PG in reconstruction.13
There was no difference between the two groups of pa-
tients when preoperative investigative methods were com-
pared. Most patients had combined CT and ERCP and pre-
or intraoperative histological confirmation of malignancy
before PD was performed. This reflects the conservative
approach of the department to what is traditionally regarded
as a major procedure with high mortality and morbidity. Pre-
operative angiography to assess resectability was not routine
in our practice and was used in only one case. Laparoscopic
evaluation was not used. Towards the latter part of the series,
there was a trend towards using magnetic resonance imaging
for preoperative assessment.
This study confirmed our subjective impression of im-
proving PD results in our institution to a mortality rate com-
parable to that in other high-volume centres. With the de-
crease in mortality (2.3% in the latter half of the series) and
morbidity, it would seem reasonable to expand the indica-
tions for this procedure to benign conditions and to proceed
to performing PD in patients with clinically suspicious
periampullary lesions without mandatory pre- or intraopera-
tive histological confirmation of malignancy. After all, as
this study has shown, 91% of such lesions were proven to be
malignant on final histological examination of the speci-
mens.
Our results suggest that the introduction of HPB sub-
specialization in the department has reduced the mortality
rate to a low of 2.3% and surgery-related complications to
16.3%. This is consistent with data showing a correlation be-
tween volume of cases and perioperative mortality rates.14,15 In
addition, our practice has changed significantly towards PG as
our anastomosis of choice, with a rate of anastomotic leak of
0%. The improvements in the rates of mortality and morbidity
in our practice have reduced the need for histological confir-
mation prior to PD as well as expanded the indications to
include benign conditions.
References
1. Whipple AO, Parsons WB, Mullins CR. Treatment of cancer of the
ampulla of Vater. Ann Surg 1935;102:763–79.
2. Crile G Jr. The advantages of bypass operations over radical pan-
creatoduodenectomy in the treatment of pancreatic carcinoma. Surg
Gynecol Obstet 1970;130:1049–53.
3. Delcore R, Thomas JH, Hermreck AS. Pancreaticoduodenectomy
for malignant pancreatic and periampullary neoplasms in elderly
patients. Am J Surg 1991;162:532–6.
4. Grace PA, Pitt HA, Tompkins RK, et al. Decreased morbidity and
mortality after pancreatoduodenectomy. Am J Surg 1986;151:141–9.
5. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive
pancreaticoduodenectomies in the 1990s: pathology, complications,
and outcomes. Ann Surg 1997;226:248–60.
6. Trede M, Schwall G. The complications of pancreatectomy. Ann Surg
1988;207:39–47.
7. Braasch JW, Deziel DJ, Rossi RL, et al. Pyloric and gastric preserving
pancreatic resection. Experience with 87 patients. Ann Surg 1986;
204:411–8.
8. Cameron JL, Pitt HA, Yeo CJ, et al. One hundred and forty-five
consecutive pancreaticoduodenectomies without mortality. Ann
Surg 1993;217:430–8.
9. Yeo CJ, Cameron JL. Improving results of pancreaticoduodenec-
tomy for pancreatic cancer. World J Surg 1999;23:907–12.
10. Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity,
mortality, and survival after the Whipple procedure. Ann Surg 1987;
206:358–65.
11. Cameron JL, Crist DW, Sitzmann JV, et al. Factors influencing sur-
vival following pancreaticoduodenectomy for pancreatic cancer.
Am J Surg 1991;161:120–5.
12. Ong HS, Ng EH, Heng G, Soo KC. Pancreaticoduodenectomy with
pancreaticogastrostomy: assessment of patients’ nutritional status,
quality of life and pancreatic exocrine function. Aust NZ J Surg 2000;
70:199–203.
13. Yeo CJ, Cameron JL, Maher MM, et al. A prospective randomized
trial of pancreaticogastrostomy versus pancreaticojejunostomy af-
ter pancreaticoduodenectomy. Ann Surg 1995;222:580–92.
14. Gordon TA, Burleyson GP, Tielsch JM, Cameron JL. The effects of
regionalization on cost and outcome for one general high-risk
surgical procedure. Ann Surg 1995;221:43–9.
15. Lieberman MD, Kilburn H, Lindsey M, Brennan MF. Relation of
perioperative deaths to hospital volume among patients undergo-
ing pancreatic resection for malignancy. Ann Surg 1995;222:638–45.
